Blog

Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.

Open filters
Search
Tags
Author
Aditi Singhai
Alison Sathe
Anders Vinther
Anne-Caroline Boillot
Barbara W. Unger
Barry Price
Jackie Torfin
Jerry Chapman
Jon Falker
Katie Terry
Khushboo Agrawal
Mark Agostino
Michael de la Torre
Rebecca Stauffer
Redica Systems
Roger Angarita
Sarah Boynton
Scott Sherrill
Tashil Sharma
Subscribe to our Newsletter
Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.

How to Address Gene Therapy Manufacturing Challenges

No items found.
Conference Spotlight

Is Your Quality System Up to Par for Your Next FDA Inspection?

No items found.
Trends

Instant Download | Yes, Warehouses Must Comply with Relevant GMPs

No items found.
Conference Spotlight

How One Pharma Firm Ensures Robust GMP CAPA Effectiveness at CMOs

No items found.

Resources for Adopting Risk-Based Thinking

No items found.

The 7 Most Common FDA 483 Observations Involving UDI

No items found.

Check Out Our Recent Free GMP Webinars

No items found.

How Can Medical Device Manufacturers Plan for the Next FDA Inspection?

No items found.
Trends

Instant Download | FY2020 and FY2021 Drug GMP Warning Letter Analysis

No items found.
Conference Spotlight

UDI Compliance for Medical Devices: Part II

No items found.
Conference Spotlight

ICH Q9: Quality Risk Management Revision Focuses on Six Topic Areas

No items found.

What is CAPA?

No items found.

FDA Regulators Address GMP Compliance Issues

No items found.
Trends

Instant Download | Analysis of COVID-19 Vaccine and Drug 483s

No items found.
Conference Spotlight

What is the Best Way to Prepare for an FDA inspection?

No items found.

On-Demand Webinar | UDI: Aligning to a Single Approach

No items found.

FDA Inspection Readiness Part IV: The FDA Inspection is Over, What Happens Next?

No items found.

Can Quality Culture Prevent GMP Issues Such as Data Integrity?

No items found.